A Bayesian network model for biomarker-based dose response.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 20412521)

Published in Risk Anal on April 20, 2010

Authors

C Eric Hack1, Lynne T Haber, Andrew Maier, Paul Shulte, Bruce Fowler, W Gregory Lotz, Russell E Savage

Author Affiliations

1: Toxicology Excellence for Risk Assessment (TERA), Cincinnati, OH, USA. charles.hack@wpafb.af.mil

Articles by these authors

Novel p47(phox)-related organizers regulate localized NADPH oxidase 1 (Nox1) activity. Sci Signal (2009) 1.29

Mechanism of p21-activated kinase 6-mediated inhibition of androgen receptor signaling. J Biol Chem (2003) 1.24

Priorities for development of research methods in occupational cancer. Environ Health Perspect (2003) 1.15

Antagonistic cross-talk between Rac and Cdc42 GTPases regulates generation of reactive oxygen species. J Biol Chem (2004) 1.09

Linear low-dose extrapolation for noncancer heath effects is the exception, not the rule. Crit Rev Toxicol (2011) 1.07

Recent advances in research on radiofrequency fields and health: 2001-2003. J Toxicol Environ Health B Crit Rev (2007) 0.96

Role of the aryl hydrocarbon receptor in cell cycle regulation. Toxicology (2002) 0.88

Resources for global risk assessment: the International Toxicity Estimates for Risk (ITER) and Risk Information Exchange (RiskIE) databases. Toxicol Appl Pharmacol (2008) 0.88

The evolution of skin notations for occupational risk assessment: a new NIOSH strategy. Regul Toxicol Pharmacol (2011) 0.87

Evaluation of concentration-response options for diacetyl in support of occupational risk assessment. Regul Toxicol Pharmacol (2010) 0.87

Chronic ingestion of (3R,3'R,6'R)-lutein and (3R,3'R)-zeaxanthin in the female rhesus macaque. Invest Ophthalmol Vis Sci (2006) 0.84

Impact of chemical proportions on the acute neurotoxicity of a mixture of seven carbamates in preweanling and adult rats. Toxicol Sci (2012) 0.84

Confirmation of an acute no-observed-adverse-effect and low-observed-adverse-effect level for copper in bottled drinking water in a multi-site international study. Regul Toxicol Pharmacol (2003) 0.83

Recent advances in research on radiofrequency fields and health: 2004-2007. J Toxicol Environ Health B Crit Rev (2009) 0.82

Correlation of chemical structure with reproductive and developmental toxicity as it relates to the use of the threshold of toxicological concern. Regul Toxicol Pharmacol (2011) 0.81

An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: examples with warfarin and parathion. Toxicol Sci (2002) 0.81

Efficacy of predictive modeling as a scientific criterion in dermal hazard identification for assignment of skin notations. Regul Toxicol Pharmacol (2011) 0.80

Assessing biomarker use in risk assessment--a survey of practitioners. J Toxicol Environ Health A (2004) 0.80

Evaluation of human relevance and mode of action for tunica vaginalis mesotheliomas resulting from oral exposure to acrylamide. Regul Toxicol Pharmacol (2008) 0.80

Carcinogen biomonitoring in human exposures and laboratory research: validation and application to human occupational exposures. Toxicol Lett (2002) 0.80

A four-step approach to evaluate mixtures for consistency with dose addition. Toxicology (2012) 0.79

Application of the threshold of toxicological concern concept to pharmaceutical manufacturing operations. Regul Toxicol Pharmacol (2005) 0.79

Scientific criteria used for the development of occupational exposure limits for metals and other mining-related chemicals. Regul Toxicol Pharmacol (2002) 0.79

Cumulative Risk Assessment (CRA): transforming the way we assess health risks. Environ Sci Technol (2012) 0.78

Temporal changes in K-ras mutant fraction in lung tissue of big blue B6C3F₁ mice exposed to ethylene oxide. Toxicol Sci (2013) 0.78

Derived Reference Doses (RfDs) for the environmental degradates of the herbicides alachlor and acetochlor: results of an independent expert panel deliberation. Regul Toxicol Pharmacol (2010) 0.77

Prenatal Programming and Toxicity II (PPTOX II): role of environmental stressors in the developmental origins of disease. Reprod Toxicol (2010) 0.77

Application of Markov chain Monte Carlo analysis to biomathematical modeling of respirable dust in US and UK coal miners. Regul Toxicol Pharmacol (2013) 0.76

Analysis of in vivo mutation data can inform cancer risk assessment. Regul Toxicol Pharmacol (2008) 0.76

A framework for fit-for-purpose dose response assessment. Regul Toxicol Pharmacol (2013) 0.76

Metal ions affecting the hematological system. Met Ions Life Sci (2011) 0.76

Dose-response approaches for nuclear receptor-mediated modes of action for liver carcinogenicity: Results of a workshop. Crit Rev Toxicol (2013) 0.75

Unstable sitting in the workplace--are there physical activity benefits? Am J Health Promot (2015) 0.75

Advancing human health risk assessment: integrating recent advisory committee recommendations. Crit Rev Toxicol (2013) 0.75

Obituary. Dr. Maths Berlin. Med Lav (2015) 0.75

Peer consultation on relationship between PAC profile and toxicity of petroleum substances. Regul Toxicol Pharmacol (2012) 0.75

Methods and measurements for estimating human dermal uptake of volatile organic compounds and for deriving dermal permeability coefficients. Toxicol Mech Methods (2007) 0.75

A look at state-level risk assessment in the United States: making decisions in the absence of federal risk values. Risk Anal (2012) 0.75

Two-dimensional electrophoretic protein profile analysis following exposure of human uroepithelial cells to occupational bladder carcinogens. Cancer Lett (2004) 0.75

A summary of the workshop applying biomarkers to occupational health practice. J Occup Environ Hyg (2004) 0.75

Critical review of dose-response options for F344 rat mammary tumors for acrylamide - additional insights based on mode of action. Food Chem Toxicol (2012) 0.75